Citation Impact
Citing Papers
RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma
2014
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
2015
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment
2019
Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
2019
Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment
2019
Head and neck squamous cell carcinoma
2020 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Nano-based smart pesticide formulations: Emerging opportunities for agriculture
2018 Standout
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
2016 Standout
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Immunotherapy applications of carbon nanotubes: from design to safe applications
2014
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins
2009
Decreased non-specific adhesivity, receptor targeted (DART) nanoparticles exhibit improved dispersion, cellular uptake, and tumor retention in invasive gliomas
2017
Cancer and viral infections in immunocompromised individuals
2009
Nasopharyngeal carcinoma
2019 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication
2005
Oncogenic activities of human papillomaviruses
2009
Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal/immune cancer therapy
2014
Controlled drug delivery vehicles for cancer treatment and their performance
2018 Standout
Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
2013
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
The human papillomavirus E7 oncoprotein
2008
Biomaterials for vaccine-based cancer immunotherapy
2018
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Trial watch: Dendritic cell-based anticancer therapy
2014
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Therapeutic vaccines for cancer: an overview of clinical trials
2014
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes
2008
Centriole overduplication through the concurrent formation of multiple daughter centrioles at single maternal templates
2007
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Trial watch: IDO inhibitors in cancer therapy
2014
Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy
2016
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Id family of helix-loop-helix proteins in cancer
2005
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
Role of indoleamine 2,3-dioxygenase in health and disease
2015
Human Papillomavirus Type 16 E7 Oncoprotein Associates with the Centrosomal Component γ-Tubulin
2007
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
2017 Standout
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Carbon nanotubes: a novel material for multifaceted applications in human healthcare
2016
Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies
2015
Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites
2016
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Combinatorial Photothermal and Immuno Cancer Therapy Using Chitosan-Coated Hollow Copper Sulfide Nanoparticles
2014
Bias in the αβ T‐cell repertoire: implications for disease pathogenesis and vaccination
2011
Dynamics of the Cytotoxic T Cell Response to a Model of Acute Viral Infection
2015
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Metronomic chemotherapy and immunotherapy in cancer treatment
2017
Works of Edwin R. Manuel being referenced
Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice
2012
Carbon Nanotubes Enhance CpG Uptake and Potentiate Antiglioma Immunity
2010
Systemic Delivery of Salmonella typhimurium Transformed with IDO shRNA Enhances Intratumoral Vector Colonization and Suppresses Tumor Growth
2012
Salmonella -Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors
2015
Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growth
2019
A road less traveled paved by IDO silencing
2013
Cyclin-dependent kinase inhibitor indirubin-3′-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies
2004
Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model
2016
Heterologous Prime/Boost Immunization With p53-based Vaccines Combined With Toll-like Receptor Stimulation Enhances Tumor Regression
2010
Survivin the battle against immunosuppression
2012
Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model
2010
The helix–loop–helix protein ID1 localizes to centrosomes and rapidly induces abnormal centrosome numbers
2004
Contribution of T-Cell Receptor Repertoire Breadth to the Dominance of Epitope-Specific CD8+T-Lymphocyte Responses
2006
TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs
2017